Rethinking HCC – Las Vegas, NV (PST)
This live activity is focused on treatment strategies for patients with hepatocellular carcinoma (HCC).
This live activity is focused on treatment strategies for patients with hepatocellular carcinoma (HCC).
This activity will cover the treatment and management of patients with non-small cell lung cancer (NSCLC).
This activity will cover the treatment and management of patients with non-small cell lung cancer (NSCLC).
This live activity will cover treating and managing atopic dermatitis in pediatric and adolescent patients.
This program will review the use of CDK 4/6 inhibitors in the treatment of HR+/HER2-negative breast cancer and the management of treatment-related adverse events.
This activity will cover the treatment and management of patients with non-small cell lung cancer (NSCLC).
This program will review current and emerging therapies for the management of moderate-to-severe uncontrolled asthma.
This program will review the use of CDK 4/6 inhibitors in the treatment of HR+/HER2-negative breast cancer and the management of treatment-related adverse events.
This program will review current and emerging therapies for the management of moderate-to-severe uncontrolled asthma.
This activity will cover the treatment and management of patients with AML.
This case-based live activity will cover the treatment and management of patients with hemophilia A
This program will review current and emerging therapies for the management of HER2-positive gastric cancer.